Digital Health Inside Out

In this episode of Digital Health Vitals, we break down the biggest stories shaping digital health, healthcare AI, health tech investing, payer strategy, value-based care, and digital health startup funding in 2026. If you’re interested in AI in healthcare, digital health funding, healthcare startups, value-based care, payer-provider dynamics, clinical AI, healthcare public markets, or health tech business models, this episode is for you.

What happens when one of digital health’s sharpest observers sits down to talk about AI hype, health tech media, IPOs, storytelling, and the future of the industry?In this episode of Digital Health Inside Out, we speak with Christina Farr, a former CNBC reporter, CEO of Second Opinion, and GP at Scrub Capital, advisor, podcaster, and one of the most thoughtful voices in healthcare innovation.We talked about Christina’s transition from journalism into venture and media, whether she could have had a bigger impact by staying in reporting, the problem with how healthcare AI talks about job loss, why most companies still tell bad stories, what founders should share more openly, whether the digital health IPO window is really reopening, why Big Tech keeps struggling in healthcare, and whether AI scribes are a real breakthrough or just the latest wave of hype.This was an honest, nuanced, and at times uncomfortable conversation — exactly the kind we like to have on this channel.If you enjoy candid conversations about digital health, healthcare AI, startups, venture capital, and the realities behind the headlines, subscribe to the channel.

In this episode of Digital Health Interviews, we sit down with Shiv Rao, CEO and co-founder of Abridge, to talk about the real future of ambient AI in healthcare. We also get into some of the harder questions: valuation hype, investor influence, FDA regulation, liability, Epic’s role in the market, and what healthcare may look like as AI becomes more deeply embedded into clinical workflows.

In Digital Health Vitals, Episode 5, we break down the biggest digital health news shaping 2026 — from major investments and acquisitions to the growing race for AI-powered healthcare platforms. If you’re a founder, investor, operator, or clinician trying to understand where digital health and AI in healthcare are heading, this episode will give you a clear, practical perspective.

In Digital Health Vitals, Episode 4, we break down the most important and controversial developments shaping digital health, AI in healthcare, and the business of care delivery — from startup bankruptcies to AI scribes and the monetization of clinical evidence driving the healthcare innovation ecosystem right now.

A fast-paced briefing on the latest AI and digital health developments shaping care and data.We cover ChatGPT Health, AI prescription pilots, celebrity-driven GLP-1 programs, and ambient scribe studies, with practical takeaways for operators navigating evidence, ethics, and ROI in 2026.

The first episode of our new interview format features Halle Tecco, healthcare entrepreneur, investor, and author.We dive into why healthcare is so hard to change, why many ideas fail, and what it truly takes to build innovation that works in the real world.

The final 2025 episode of Digital Health Vitals delivers a concise briefing for healthcare operators.We cover key headlines and year-end highlights, giving a clear view of the market and what to watch in early 2026.

A monthly, operator-focused briefing highlighting the most important and actionable digital health news.We cut through the noise to deliver practical insights on AI tools, platform dynamics, KPIs, and strategies clinics, payers, and health-tech teams can apply immediately.

A deep dive into why women’s health and femtech startups still face funding challenges in 2025.We explore investor bias, regulatory hurdles, and systemic barriers, asking whether the funding gap for women-led teams is changing—or holding the ecosystem back.

A grounded discussion on longevity, separating real science from marketing hype as the field goes mainstream.We explore what changed in recent years, key longevity metrics, the influencer effect, and where attention truly belongs—from lifestyle fundamentals to supplements and GLP-1 drugs.

A candid debate on whether value-based care is a real alternative to fee-for-service or an expensive illusion.We examine what “value” really means, which metrics matter, and whether VBC success stories can truly scale beyond isolated cases.

An in-depth look at the crowded medical AI scribe market and why so many tools exist for the same problem.We examine where the real innovation lies, the risks involved, and whether AI scribes truly move healthcare toward value-based care—or just attract VC hype.

A sharp debate on whether VC culture has harmed digital health, unpacking how aggressive investment tactics shape innovation, sustainability, and exits.We explore the future of digital health funding and whether AI can help founders rely less on venture capital.

A clear-eyed discussion on Generative AI in healthcare, separating real clinical impact from hype.We break down where AI truly improves patient care and diagnostics—and where the promises fall short.